Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Triple-Negative Breast Carcinoma|Breast Cancer
Interventions: DRUG: Neratinib Oral Tablet|DRUG: Ruxolitinib Oral Tablet
Sponsor: Baylor Research Institute